New aspects on reperfusion injury to liver--impact of organ harvest
- PMID: 15240846
- DOI: 10.1093/ndt/gfh1038
New aspects on reperfusion injury to liver--impact of organ harvest
Abstract
The aetiology of primary graft non-function and dysfunction is unknown but most likely involves Kupffer cell-dependent reperfusion injury; however, reasons for transplant failure are complex and involve organ retrieval, preservation and transplantation. Important factors include the donor's condition, cold and warm ischaemic times, operative complications in the recipient, the immune status of the recipient and surgical experience. The donor operation and surgical technique also have an effect on outcome after transplantation. This is important, since surgical organ manipulation of the liver during harvest cannot be prevented completely with standard procedures. This is especially true during organ harvest for living-donor liver transplantation and split-liver transplantation in general. Most recently, an experimental setting has conclusively demonstrated that gentle in situ organ manipulation by touching, retracting and moving liver lobes gently during harvest dramatically reduces survival after transplantation via Kupffer cell-dependent mechanisms. These mechanisms involve disturbances of hepatic microcirculation, a hypermetabolic state of the liver, hypoxia and almost complete denudation of endothelial lining cells. Glycine, a non-essential, non-toxic amino acid, which prevents activation of Kupffer cells, prevented all effects of harvest-related injury to the liver when given before transplantation. Based on these data, intravenous glycine has been administered to patients before reperfusion of their liver transplant. Both serum transaminases and the rate of primary non-function have been dramatically reduced, compared with historic controls. These preliminary clinical results with glycine before reperfusion are promising for further improvement of the overall outcome after liver transplantation.
Similar articles
-
[Preparing the donor with glycine improves survival after liver transplantation in the animal model].Langenbecks Arch Chir Suppl Kongressbd. 1998;115(Suppl I):589-93. Langenbecks Arch Chir Suppl Kongressbd. 1998. PMID: 14518323 German.
-
Kupffer cell-dependent reperfusion injury in liver transplantation: new clinically relevant use of glycine.Langenbecks Arch Chir Suppl Kongressbd. 1998;115:185-90. Langenbecks Arch Chir Suppl Kongressbd. 1998. PMID: 9931608 Review.
-
Intravenous glycine improves survival in rat liver transplantation.Am J Physiol. 1999 Apr;276(4):G924-32. doi: 10.1152/ajpgi.1999.276.4.G924. Am J Physiol. 1999. PMID: 10198336
-
Benefit of Kupffer cell modulation with glycine versus Kupffer cell depletion after liver transplantation in the rat: effects on postischemic reperfusion injury, apoptotic cell death graft regeneration and survival.Transpl Int. 2005 Sep;18(9):1079-89. doi: 10.1111/j.1432-2277.2005.00185.x. Transpl Int. 2005. PMID: 16101730
-
Non beating heart donors as a possible source for liver transplantation.Acta Chir Belg. 2000 Nov-Dec;100(6):268-71. Acta Chir Belg. 2000. PMID: 11236181 Review.
Cited by
-
Preservation of non-heart-beating donor livers in extracorporeal liver perfusion and histidine-trytophan-ketoglutarate solution.World J Gastroenterol. 2008 Apr 21;14(15):2338-42. doi: 10.3748/wjg.14.2338. World J Gastroenterol. 2008. PMID: 18416459 Free PMC article.
-
Control of Ischemia-Reperfusion Injury in Liver Transplantation: Potentials for Increasing the Donor Pool.Visc Med. 2018 Dec;34(6):444-448. doi: 10.1159/000493889. Epub 2018 Oct 30. Visc Med. 2018. PMID: 30675491 Free PMC article. Review.
-
Effluent Molecular Analysis Guides Liver Graft Allocation to Clinical Hypothermic Oxygenated Machine Perfusion.Biomedicines. 2021 Oct 11;9(10):1444. doi: 10.3390/biomedicines9101444. Biomedicines. 2021. PMID: 34680561 Free PMC article.
-
Evaluation of Graft Effluent High Mobility Group Box-1 (HMGB-1) for Prediction of Outcome After Liver Transplantation.Ann Transplant. 2018 Jul 13;23:475-480. doi: 10.12659/AOT.909165. Ann Transplant. 2018. PMID: 30002362 Free PMC article.
-
HEGPOL: randomized, placebo controlled, multicenter, double-blind clinical trial to investigate hepatoprotective effects of glycine in the postoperative phase of liver transplantation [ISRCTN69350312].BMC Surg. 2005 Aug 17;5:18. doi: 10.1186/1471-2482-5-18. BMC Surg. 2005. PMID: 16105183 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical